3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
102
Lung Neoplasms
39
Neoplasms
11
Neoplasm Metastasis
11
Colorectal Neoplasms
9
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Pancreatic Neoplasms
6
Mesothelioma, Malignant
5
Mesothelioma
5
Carcinoma
5
Ovarian Neoplasms
4
Meningeal Carcinomatosis
4
Melanoma
4
Colonic Neoplasms
4
Advanced Solid Tumors
4
Rectal Neoplasms
3
Adenocarcinoma of Lung
3
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Non-squamous Non-small Cell Lung Cancer
2
Neoplasms by Site
2
Lung Diseases
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Pancreatic Ductal
2
Carcinoma, Bronchogenic
2
Bronchial Neoplasms
2
Brain Neoplasms
2
Interventions
Carboplatin
5
Cisplatin
3
zipalertinib
2
Pemetrexed
2
Paclitaxel
2
Nivolumab
2
Blood Specimen Collection
2
zimberelimab
1
selpercatinib
1
sacituzumab govitecan
1
repotrectinib
1
pembrolizumab
1
durvalumab
1
atezolizumab
1
alectinib
1
Toll-Like Receptor 1
1
Surveys and Questionnaires
1
One-Lung Ventilation
1
Ipilimumab
1
Health Records, Personal
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Lung Diseases
×
Pemetrexed
×
90 days
×
Clear all
NCT06119581
2026-06-03
SUNRAY-01
Eli Lilly and Company
Phase 3
Recruiting
1,264 enrolled
NCT05012254
2026-05-05
NIVIPI-Brain
Fundación GECP
Phase 2
Active not recruiting
71 enrolled